Close

Point72 Asset Management, L.P. Shows New 8.3% Stake in Celator Pharmaceuticals (CPXX)

March 15, 2016 4:21 PM EDT

In a 13G filing on Celator Pharmaceuticals (NASDAQ: CPXX), Steven Cohen Point72 Asset Management, L.P. disclosed a 8.3%, or 2,855,000 share, stake in the company.

Shares of CPXX surged 432% intra-day on the back of positive trial data.

For more notable holders of Celator Pharmaceuticals stock click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

13Gs, Hedge Funds, Momentum Movers, Trader Talk

Related Entities

SAC Capital, Steven A. Cohen, 13G, Point72 Asset